MULTIDISCIPLINARY SUPPORT FOR BUPRENORPHINE-NALOXONE TREATMENT OF OPIOID USE DISORDER

被引:0
|
作者
Hall, A. [1 ]
机构
[1] Univ Washington, Sch Med, Seattle, WA USA
关键词
D O I
10.1136/jim-2019-WMRC.175
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
175
引用
收藏
页码:A75 / A75
页数:1
相关论文
共 50 条
  • [41] Treatment of Kratom Dependence With Buprenorphine-Naloxone Maintenance
    Buresh, Megan
    JOURNAL OF ADDICTION MEDICINE, 2018, 12 (06) : 481 - 483
  • [42] Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence
    Fiellin, David A.
    Pantalon, Michael V.
    Chawarski, Marek C.
    Moore, Brent A.
    Sullivan, Lynn E.
    O'Connor, Patrick G.
    Schottenfeld, Richard S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (04): : 365 - 374
  • [43] Buprenorphine-naloxone microdosing Tool for opioid agonist therapy induction
    Marwah, Radhika
    Coons, Caitlin
    Myers, Jacqueline
    Dumont, Zack
    CANADIAN FAMILY PHYSICIAN, 2020, 66 (12) : 891 - 894
  • [44] Buprenorphine and Naloxone Versus Buprenorphine for Opioid Use Disorder in Pregnancy: A Cohort Study
    Mullins, Nathan
    Galvin, Shelley L.
    Ramage, Melinda
    Gannon, Marie
    Lorenz, Kathleen
    Sager, Brent
    Coulson, Carol C.
    JOURNAL OF ADDICTION MEDICINE, 2020, 14 (03) : 185 - 192
  • [45] Depression and Suicidal Ideation in Adults With Opioid Use Disorder Treated With Buprenorphine-Naloxone Versus Extended-Release Naltrexone
    Rizk, Mina
    Stanley, Barbara
    Choo, Tse-Hwei
    Pavilcova, Martina
    Scodes, Jennifer
    Campbell, Aimee
    Nunes, Edward
    Rotrosen, John
    BIOLOGICAL PSYCHIATRY, 2020, 87 (09) : S268 - S269
  • [46] Opioid use disorder and type 2 diabetes mellitus Effect of participation in buprenorphine-naloxone substitution programs on glycemic control
    Tilbrook, Devon
    Jacob, Jeffrey
    Parsons, Pierre
    Edwards, Craig
    Loewen, Kassandra
    Kelly, Len
    CANADIAN FAMILY PHYSICIAN, 2017, 63 (07) : E350 - E354
  • [47] Pain severity and subsequent opioid use during buprenorphine-naloxone treatment of prescription opioid-dependent patients with chronic pain
    Weiss, Roger
    Griffin, Margaret L.
    McDermott, Katherine
    McHugh, Kathryn
    Karakula, Sterling L.
    Fitzmaurice, Garrett
    DRUG AND ALCOHOL DEPENDENCE, 2017, 171 : E215 - E216
  • [48] Home induction and outpatient treatment of kratom use disorder with buprenorphine-naloxone: A case report in a young adult
    Schmuhl, Kelsey K.
    Gardner, Spencer M.
    Cottrill, Casey B.
    Bonny, Andrea E.
    SUBSTANCE ABUSE, 2020, 41 (03) : 311 - 314
  • [49] Does Early Response to Buprenorphine-Naloxone Predict Treatment Outcome in Prescription Opioid Dependence?
    Weiss, Roger
    AMERICAN JOURNAL ON ADDICTIONS, 2015, 24 (01): : 67 - 68
  • [50] Co-occurring Depression in Patients With Opioid Use Disorder: Prevalence and Response During Treatment With Buprenorphine-Naloxone or Extended- Release Naltrexone
    Na, Peter
    Scodes, Jennifer
    Pavlicova, Martina
    Fishman, Marc
    Rotrosen, John
    Nunes, Edward
    AMERICAN JOURNAL ON ADDICTIONS, 2021, 30 (03): : 253 - 253